Jiangsu Nhwa Pharmaceutical Co., Ltd.
002262
株式のランク
#4605
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
株価
$3.28
時価総額
$3.32B
変化（1日）
4.19%
変化（1年）
-10.41%
国
CN
取引 Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
カテゴリー
Healthcare
Jiangsu Nhwa Pharmaceutical Co., Ltd.（002262）のP/B比率
October 2026 時点のP/B比率 TTM: 2.55
Jiangsu Nhwa Pharmaceutical Co., Ltd. の最新の財務報告および株価によると、現在のP/B比率（TTM）は 2.55 です。2023 年末時点でのP/B比率は 4.30 でした。
Jiangsu Nhwa Pharmaceutical Co., Ltd. の P/B 比率の履歴（2005 ～ 2026）
各年末時点のP/B比率
| 年 | P/B比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 2.55 | -24.63% |
| 2024 | 3.38 | -21.41% |
| 2023 | 4.30 | -2.38% |
| 2022 | 4.40 | 37.29% |
| 2021 | 3.20 | -18.27% |
| 2020 | 3.92 | 20.59% |
| 2019 | 3.25 | 9.26% |
| 2018 | 2.98 | -47.37% |
| 2017 | 5.65 | -10.10% |
| 2016 | 6.29 | -18.49% |
| 2015 | 7.72 | -17.46% |
| 2014 | 9.35 | -15.16% |
| 2013 | 11.02 | 47.24% |
| 2012 | 7.48 | 30.38% |
| 2011 | 5.74 | -33.54% |
| 2010 | 8.64 | 39.42% |
| 2009 | 6.19 | 73.28% |
| 2008 | 3.58 | -72.45% |
| 2007 | 12.98 | 12.26% |
| 2006 | 11.56 | 24.47% |
| 2005 | 9.29 | 0.00% |
同業他社のP/B比率
| 企業 | P/B比率 | P/B比率の差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 97.87% |
IN
|
